AVAlexander O. Vasilyev

Alexander O. Vasilyev

*This is an algorithmically generated author record based on publicly available information.

Alexander O. Vasilyev has a total of 199 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Radical prostatectomy without prior biopsy: Current state of the problem

    by F. A. Medvedev, A. V. Govorov, A. O. Vasilyev, P. A. Arutyunyan, L. V. Reshetov, K. B. Kolontarev, D. Yu. Pushkar, Ф. А. Медведев, А. В. Говоров, А. О. Васильев, et al.

    Introduction. Prostate biopsy remains a key step in the morphological verification of prostate cancer (PC) before treatment selection; however, it is an invasive procedure and may be associated with infectious complications, hematuria, and acute urinary retention. Advances in multiparametric magnetic resonance imaging and prostate-specific membrane antigen positron emission tomography / computed tomography have improved the accuracy of non-invasive assessment of the likelihood of clinically significant prostate cancer and have led to discussion on the feasibility of radical prostatectomy without prior morphological verification in carefully selected patients. Potential advantages of this approach include omission of biopsy and biopsy-related complications, shortening the diagnostic pathway, and reduction of the time to radical treatment; however, the risk of surgical overtreatment due to false-positive imaging findings remains. Objective. To analyze published data on the feasibility of radical prostatectomy without prior prostate biopsy in carefully selected patients with high likelihood of clinically significant prostate cancer. Materials and methods. Publications indexed in PubMed, Scopus, Web of Science and eLIBRARY, as well as articles identified on scientific publishing platforms and through reference lists, were analyzed for the period from 2010 to 2026. Fourteen publications relevant to the topic were included in the review: 5 prospective cohort studies, 5 retrospective cohort studies, 3 literature reviews, and 1 case report. No systematic reviews or metaanalyses directly addressing radical prostatectomy without prior prostate biopsy were identified. Results. In most studies, radical prostatectomy without prior morphological verification was performed in patients with a high likelihood of clinically significant prostate cancer based on a combination of clinical, laboratory, and imaging findings. The most used selection criteria included elevated prostate-specific antigen levels, abnormal digital rectal examination findings, PI-RADS 4–5 lesions on multiparametric magnetic resonance imaging, and high likelihood of malignancy on prostate-specific membrane antigen positron emission tomography / computed tomography. In most published series, final histopathological examination confirmed prostate cancer, with a high proportion of clinically significant tumors. At the same time, cases of clinically insignificant prostate cancer, high-grade prostatic intraepithelial neoplasia, and absence of malignancy in the surgical specimen have been reported, indicating a persistent risk of surgical overtreatment. Comparative data did not demonstrate advantages of omitting prior biopsy in terms of recovery of urinary continence, erectile function, or quality of life. A promising direction is the use of intraoperative morphological verification followed by radical treatment within a single anesthetic procedure. Conclusion. Radical prostatectomy without prior prostate biopsy cannot currently be regarded as a standard approach. Its use may be considered in carefully selected patients with a high likelihood of clinically significant prostate cancer based on comprehensive clinical, laboratory, and imaging assessment. The main limitations are the risk of unjustified radical treatment and the absence of morphological data required for comprehensive preoperative risk stratification. Further prospective studies are needed to develop reproducible patient-selection criteria and to evaluate the diagnostic accuracy, oncological safety, and clinical effectiveness of this strategy.

  • Open Access

    Robot-assisted radical prostatectomy using the Edge Medical MP1000 multi-port surgical robotic system: Experience with 8 cases

    by D. Yu. Pushkar, K. B. Kolontarev, A. V. Govorov, V. V. Dyakov, A. O. Vasilyev, A. I. Alaverdyan, A. D. Markov, Д. Ю. Пушкарь, К. Б. Колонтарев, А. В. Говоров, et al.

    Background . Expansion of the surgical platform market due to rapid introduction and clinical implementation of new robotic systems necessitates an objective assessment of efficacy and safety of the new robotic platforms in comparison with the established platforms. The Edge Medical MP1000 multi-port surgical robotic system is a modern platform featuring 3D high-definition visualization and a reported latency of ≤40 ms. The MP1000 surgical platform has been used successfully for more than 6,000 procedures in urology, gynecology, general surgery, and thoracic surgery demonstrating high technological maturity and versatility of this surgical platform. MP1000 robotic system was successfully installed at the Moscow Multidisciplinary Research and Clinical Center named after S.P. Botkin in October 2025, expanding the institution’s surgical capabilities and opening new prospects for the adoption of innovative approaches in robotic urological surgery. Aim . To assess the feasibility and safety of robot-assisted radical prostatectomy (RARP) performed using the Edge Medical MP1000 multi-port surgical system, and to analyze early oncological and functional outcomes of the procedure, to describe the technical features of the MP1000 platform relevant to surgical performance (docking, ergonomics, visualization, and usability for both the surgeon and the assistant). Materials and methods . We conducted a single-center prospective cohort study of 8 patients with localized prostate cancer who underwent RARP using the Edge Medical MP1000 multi-port surgical system. One patient also underwent pelvic lymph node dissection. The primary endpoint was the rate of conversion to open surgery. Secondary endpoints included docking time, operative time, intraoperative blood loss, the incidence and nature of intraoperative and postoperative complications according to the Clavien–Dindo classification, surgical margin status, length of hospital stay, duration of bladder catheterization, early urinary continence and erectile function outcomes, as well as the surgeon’s subjective assessment of ergonomics and console comfort. Results . All procedures were successfully completed without the need for conversion to open surgery. Mean docking time was 17.3 (11–25) minutes, and mean operative time was 197.7 minutes. Estimated intraoperative blood loss ranged from 5 to 200 mL (median 88.1 mL). Positive surgical margins were observed in 4 patients. The mean length of hospital stay was 10.5 (7–16) days. Following urethral catheter removal, all patients regained spontaneous voiding, with postvoid residual urine volume not exceeding 50 mL. Early continence (the use of one pad per day) had been achieved in 7 patients by postoperative day 30; there were no cases of severe urinary incontinence. The ergonomic characteristics of the MP1000 were comparable to those of the benchmark platform under similar conditions. No major intraoperative complications were recorded. One patient developed ureteral orifice edema requiring percutaneous nephrostomy. Conclusion . Robot-assisted radical prostatectomy performed using the Edge Medical MP1000 multi-port surgical system is a safe procedure. The early functional outcomes obtained in this series are comparable to those reported for the benchmark robotic platform (da Vinci Xi). Technical features of the system, including high-definition 3D visualization, minimal response latency, precise motion, and convenient positioning, may broaden its potential applications in urological practice. However, the study is limited by the small sample size. Multicenter studies with larger patient cohorts and longer follow-up are required to provide a definitive assessment of efficacy and reproducibility.

  • The use of fluorescence imaging with indocyanine green (ICG) for sentinel lymph node detection during robot-assisted radical prostatectomy

    by Genrikh A. Monastyrnyy, Монастырный Генрих Аркадьевич, A. O. Vasilyev, Васильев А. О., A. V. Govorov, Говоров А. В., F. A. Medvedev, Медведев Ф. А., D. Yu. Pushkar, Пушкарь Д. Ю.

    Background. Prostate cancer is the most common malignant neoplasm among men and the second leading cause of cancer-related mortality. According to studies, lymph node metastases are detected in approximately 15 % of patients after radical prostatectomy combined with extended pelvic lymph node dissection. In line with the European Association of Urology guidelines, extended pelvic lymph node dissection should be performed in high-risk prostate cancer cases and in intermediate-risk patients where validated nomograms predict a significant likelihood of lymph node involvement. Modern surgical practice emphasizes the development of high-precision intraoperative imaging techniques to enhance the efficacy of interventions. One such innovative method is near-infrared fluorescence imaging, which utilizes fluorophores – substances that emit light upon laser excitation. For example, indocyanine green (ICG) is used as a contrast agent for fluorescence-guided surgery, improving tissue structure identification and surgical precision. Aim. To evaluate the feasibility of fluorescence diagnostics using ICG during robot-assisted radical prostatectomy with extended pelvic lymph node dissection. Materials and methods. At the A. I. Evdokimov Moscow State University of Medicine and Dentistry’s Urology Clinic (based at the S. I. Spasokukotsky City Clinical Hospital, Moscow Healthcare Department), 12 patients diagnosed with prostate cancer were analyzed between 2022 and 2023. Inclusion criteria were localized prostate cancer with histologically confirmed adenocarcinoma (Gleason score ≥7 (3 + 4)) and preoperative risk of lymph node metastasis exceeding 5 % as per the A. Briganti et al. (2012) nomogram. All patients underwent robot-assisted radical prostatectomy and pelvic lymph node dissection. During surgery, intraprostatic injection of ICG solution was performed after prostate isolation, followed by fluorescence imaging of lymph nodes using the FireFly™ mode on the DaVinci Xi™ robotic system. Results. Patients were divided into two groups: Group 1 (n = 6) included patients with MRI-suspected pelvic lymph node metastases, and Group 2 (n = 6) had no imaging abnormalities. Postoperative histology revealed lymph node metastases in 5/6 patients in Group 1. In one patient from Group 1, metastatic involvement was confined to a single sentinel lymph node, which was visualized using ICG. No metastases were detected in Group 2. The mean fluorescence visualization time for pelvic lymph nodes was 17 minutes. Sentinel lymph nodes were identified in 6/12 patients, with intraoperative frozen section analysis confirming metastatic spread into these nodes. Conclusion. Intraoperative fluorescence diagnostics with ICG is a safe and practical method to improve surgical outcomes in prostate cancer treatment. ICG enhances the identification of key anatomical landmarks and pathological structures. Sentinel lymph node biopsy may reduce complications associated with extended pelvic lymph node dissection and improve staging by enabling targeted removal of metastatic lymph nodes beyond the standard pelvic lymph node dissection template.

  • Open Access

    Robot-assisted surgery: is there a role for artificial intelligence?

    by P. A. Arutyunyan, A. O. Vasiliev, F. A. Medvedev, M. A. Yurlova, A. V. Govorov, D. Yu. Pushkar

    Robotic surgery (RS) is considered a stage in the evolution of minimally invasive procedures. Despite the increasing adoption of RS, challenges remain regarding outcome reproducibility, pronounced operator dependence, learning curves, and technological and organizational constraints, which underscores the need to further develop the “digital layer” of surgery and to apply artificial intelligence (AI) for intraoperative data analysis. A systematic literature review was conducted using Russianand English-language keywords related to RS and AI. The review summarizes key directions of AI integration into robot-assisted procedures, most commonly implemented as modules for surgical video and instrument kinematic analysis, including computer vision, phase and task recognition, extraction of objective performance metrics, automated skill assessment and training support, predictive modeling of selected postoperative course parameters, and elements of partial automation of subtasks while maintaining the primacy of clinical oversight. The interpretation of published results is limited by heterogeneity in datasets and evaluation protocols, as well as differences in annotation strategies, performance metrics, and validation approaches, which complicates crossstudy comparisons and model transferability across institutions. Clinical implementation of AI is further associated with requirements for data privacy and security, cyber-resilience, model transparency, and regulatory accountability.

  • Open Access

    Detection of clinically significant prostate cancer using various biopsy techniques

    by Kerimulla K. Ramazanov, Alexander V. Govorov, Konstantin B. Kolontarev, Anton V. Sadchenko, Alexander O. Vasilyev, Roman V. Stroganov, Alexey I. Volnukhin, Shamkhan T. Turlu, Sargis S. Tumanyan, Veniamin Yu. Vengerov, et al.

    Prostate cancer is one of the most common cancers in men. Timely detection of clinically significant prostate cancer remains one of the key tasks of healthcare, while minimizing overdiagnosis of clinically insignificant prostate cancer, thereby avoiding overtreatment and resource waste. In recent decades, significant progress has been made in the diagnosis of prostate cancer, primarily due to the introduction of multiparametric magnetic resonance imaging and targeted biopsy. The sensitivity of targeted biopsy in detecting an index lesion exceeds 90%. However, systematic biopsy remains an important addition, as it helps detect 5% to 16% of clinically significant prostate cancer cases that may be missed when performing a targeted biopsy only. The utility of performing a systematic prostate biopsy when a lesion is detected on multiparametric magnetic resonance imaging remains a controversial issue. The results of most of the above procedures do not convincingly exclude the need for this biopsy. Of note, the conditions for performing multiparametric magnetic resonance imaging, the approaches and experience of urologists in performing biopsies, and the expertise of pathologists vary across different medical institutions. Centralized performance of multiparametric magnetic resonance imaging, prostate biopsy, and pathomorphological examination at expert centers is essential to improve the timely diagnosis and treatment of clinically significant prostate cancer.

  • Open Access

    Indocyanine green fluorescence navigation in robot-assisted radical prostatectomy: a literature review

    by Г. А. Монастырный, A. O. Vasilyev, A. V. Govorov, K. B. Kolontarev, V. V. Dyakov, D. Yu. Pushkar

    The aim of the study is to analyze current evidence on the use of fluorescence-guided navigation with indocyanine green (ICG) during robot-assisted radical prostatectomy (RARP) and to assess its impact on surgical accuracy and patient safety. Materials and methods . A literature review was conducted using the PubMed, Scopus, and Web of Science databases for the period 2010–2025. The search included the following key terms: indocyanine green, ICG, radical prostatectomy, robot-assisted prostatectomy, lymphadenectomy, fluorescence-guided surgery. Systematic reviews, prospective, and retrospective studies evaluating the application of ICG in RARP were analyzed. Results . The use of ICG during RARP improves intraoperative visualization of lymph nodes, neurovascular bundles, and the dorsal venous complex, thereby enhancing the accuracy of lymphadenectomy and reducing the risk of injury to critical anatomical structures. Most studies demonstrate that ICG application shortens operative time, decreases blood loss, and increases the rate of nerve-sparing procedures without raising the incidence of positive surgical margins. However, standardization of the ICG dosage and administration protocol remains lacking, and further large-scale randomized trials are required to confirm its efficacy and reproducibility. Conclusion . Fluorescence-guided surgery using indocyanine green represents a promising approach for intraoperative visualization during RARP, improving the precision and safety of surgical interventions. Further research is needed to optimize administration protocols and validate the method through multicenter clinical trials with high levels of evidence.

  • Open Access

    Assessment of Quality of Life and its Predictors in Prostate Cancer Patients

    by M. I. Maksimova, A. O. Vasiliev, A. V. Govorov, D. Yu. Pushkar

    Introduction. Improving quality of life (QoL) has become an objective equal in importance to prolonging survival in prostate cancer (PC). The objective of this work was to review the latest scientific studies assessing the QOL of patients with PC both before and after treatment. The search for scientific studies was conducted using leading international databases (PubMed, Scopus and Web of Science). Material and methods. A systematic search of PubMed, Scopus and Web of Science (2010 – 2025) was performed using the terms “prostate cancer”, “quality of life”, “postoperative outcomes”, “predictors”. 17 original studies were included. The list of questionnaires used included EPIC-26/CP, EORTC QLQ-C30/PR25, FACT-P, PROMIS and FoP-Q-SF. Results. Adverse clinicopathological predictors of poor QoL included age ≥ 65 years, multimorbidity, Gleason score ≥ 8 and prior TURP. Anatomic MRI-derived markers (short membranous urethra < 10 mm, prolonged pubic–apex length) reliably forecasted long-term incontinence and erectile dysfunction after robot-assisted prostatectomy. Psychosocial factors—fatigue, fear of cancer recurrence and insomnia–made a comparable impact: severe fatigue increased the odds of poor physical health, while high fear of recurrence reduced global QLQ-C30 scores by ≥ 10 points. High socioeconomic status and robust family support mitigate QoL deterioration by approximately 30 %. Radical treatments (prostatectomy, external-beam radiotherapy, androgen-deprivation therapy) produced persistent functional impairment yet did not worsen mental well-being when active rehabilitation programs were implemented. Conclusion. QoL in men with PC is shaped by a multifactorial interplay of clinical, anatomical and psychosocial predictors; integrating routine PROM screening with MRI-based nomograms and targeted psychosocial support enables truly personalized care.


  • Open Access

    Chatbots based on artificial intelligence in oncourology: assessment of the reliability and quality of medical information.

    by P.A. Arutyunyan, A.O. Vasilyev, A.V. Govorov, Yu.A. Kim, F.A. Medvedev, L.A. Khodyreva, D. Yu. Pushkar

    Introduction. In the era of digital progress and the development of artificial intelligence (AI) technologies, the potential application of chatbots in various fields, including medicine, has gained significant attention. With the global accessibility of the internet and the growing popularity of such services, there is an increasing need to evaluate the reliability and quality of the data generated, particularly concerning malignant neoplasms. The aim of this study was to analyze the quality of medical information related to prostate and bladder cancer using AI-based chatbots. Materials and methods. A study was conducted involving the examination and analysis of web traffic data from StatCounter. Based on the results of the web analysis to determine the leading search engine in overall web traffic in Russia, we used data from the Yandex Wordstat analytics service. We also conducted an assessment of responses from four AI-based chatbots to the most in-demand medical queries related to the two urological cancers with the highest incidence rates-prostate cancer and bladder cancer. We used publicly available versions of the four AI-based chatbots: ChatGPT, Perplexity, YaGPT, and GigaChat. To evaluate the quality of the medical information provided by the chatbots, we applied the validated DIS- CERN assessment tool. In addition, qualitative analysis and expert evaluation using DISCERN were carried out with the participation of 50 respondents-oncourologists with at least 10 years of professional experience in Russia. Results. We obtained and analyzed the evaluation results using the DISCERN scale. The highest overall score for medical information quality was achieved by the Perplexity chatbot, followed by ChatGPT in second place, and GigaChat in third. YaGPT ranked fourth and last. It is worth noting that all chatbots, to varying degrees, made errors and inaccuracies in generating medical information in response to the relevant queries. Conclusion. Today, AI-based chatbots represent a promising and in-demand direction. With the advancement of technology and the widespread adoption of software solutions, more people are turning to such services in search of authoritative medical information. However, at this stage, not all chatbots are capable of providing accurate medical content. Further development of AI architecture and internal algorithms is required, as well as the creation of standards and recommendations for integrating chatbots into medical information systems. This will help shape the direction of AI solutions for the coming decades and support both physicians and patients in diagnostics and decision-making.

  • Open Access

    Cryoablation of prostate cancer: existing limitations and prospects for further development. A review

    by Alexander O. Vasilyev, Aleksandr V. Pushkarev, Alexander V. Govorov, Natalia Yu. Saakyan, Dmitrii I. Tsiganov, Саакян Наталья Юрьевна, Цыганов Дмитрий Игоревич

    Prostate cryoablation is a minimally invasive treatment method based on the use of extremely low temperatures to destroy cancer cells. Despite the relative simplicity of positioning cryoablation needles in the target area, which makes the procedure less traumatic, this approach may have limitations when treating advanced forms of cancer. As a result, there has been a trend toward prioritizing safety over maximum treatment effectiveness, which limits the method's application in clinical practice. Ongoing research, both internationally and in the Russian Federation, aims to improve the effectiveness of cryoablation. Studies on the impact of low temperatures on prostate cancer cells are being conducted in both clinical and experimental research. This article provides an overview of current domestic and international research, identifies the main limitations of the method, and suggests prospects for its further development to overcome existing barriers.


  • Open Access

    Artificial intelligence in early diagnosis of prostate cancer.

    by Department of Urology of the «Russian University of Medicine» of the Ministry of Health of Russia on the basis of the State Budgetary Healthcare Institution MMNC named after S.P. Botkin of the Moscow Department of Health, A.O. Vasilyev, Russia Moscow, A.V. Govorov, Yu.A. Kim, P.A. Arutyunyan, D.YU. Pushkar

    Introduction. To assess the prospects of using artificial intelligence (AI) for the diagnosis and treatment of prostate cancer (PCa) and to evaluate the impact of AI on treatment efficacy. Materials and Methods. A systematic literature review was conducted using scientific databases based on key queries related to AI and PCa. Studies from the last 10 years were included. Results. AI algorithms, such as machine learning (ML) and deep learning (DL), improve the quality of PCa diagnostics, minimize subjective factors, and optimize the diagnostic process. The implementation of computer-aided detection (CAD) systems also enhances diagnostic accuracy, while the results depend on the expertise of specialists. Discussion. AI-based systems have the potential to improve diagnostics, personalize treatment, and reduce healthcare costs. However, issues related to the quality of AI training data and the interpretation of algorithms require further investigation. Conclusions. The use of AI in PCa diagnostics is a promising direction. However, additional research is needed for a comprehensive assessment of effective systems and the implementation process.